Alkermes Plc (ALKS)
33.31
-0.60
(-1.77%)
USD |
NASDAQ |
Apr 24, 16:00
33.34
+0.04
(+0.11%)
After-Hours: 20:00
Alkermes Market Cap : 5.551B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assertio Holdings, Inc. | 115.76M |
| Amarin Corp. Plc | 298.23M |
| Jazz Pharmaceuticals Plc | 12.10B |
| Regeneron Pharmaceuticals, Inc. | 79.46B |
| Xenon Pharmaceuticals, Inc. | 5.271B |
Market Cap Related Metrics
| PE Ratio | 23.25 |
| PS Ratio | 3.809 |
| Price to Book Value | 3.051 |
| Price to Free Cash Flow | 11.70 |
| Price | 33.31 |
| Earnings Yield | 4.30% |
| Operating PE Ratio | 22.14 |
| Normalized PE Ratio | 23.25 |